Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
N. Chic1, B. González-Farré2, L. Paré3, T. Pascual3, C. Saura Manich4, C. Hernando Melia5, M. Muñoz6, P. Fernandez7, D. Martínez8, E. Sanfeliu2, F. Brasó-Maristany9, X. González-Farré10, A.M. Antunes De Melo e Oliveira11, M. Gil-Gil12, P. Celiz3, E.M. Ciruelos13, P. Villagrasa14, J. Gavila Gregori15, A. Prat16
Communication in congress
Poster de resultados
ESMO BREAST
2020
